Skip to content
PeptideMatch.io
Dr. Alobeid Weight Loss Institute logo

Dr. Alobeid Weight Loss Institute

Chicago, IL5.013 Google reviews

This listing hasn't been verified by PeptideMatch. Details come from public sources and may be out of date. Confirm credentials and services directly with the clinic. About verification

About Dr. Alobeid Weight Loss Institute

Dr. Alobeid Weight Loss Institute, located in Chicago, specializes in medical weight loss using FDA-approved GLP-1 receptor agonists including semaglutide and tirzepatide, alongside IV nutrient therapy to support metabolic health and nutritional status during weight-loss protocols. The clinic offers a comprehensive, individualized approach combining pharmacologic intervention with dietary guidance and ongoing monitoring. Treatment is tailored to each patient's metabolic profile and health history. The practice also provides erectile-dysfunction treatment and offers IPL services as adjunctive options for patients pursuing broader health optimization alongside weight management. An integrated team including a registered dietitian supports sustained outcomes.

Treatments & services

Other providers near Chicago

See all nearby →
  • Chicagoland Men's Health

    Chicago, IL· <1 mi

    5.0

    • Peptide Therapy
    • Erectile Dysfunction (ED) Treatment
    • Testosterone Replacement Therapy (TRT)
    • +1 more
    Unverified listingView
  • Chicagoland Women's Health

    Chicago, IL· <1 mi

    5.0

    • Peptide Therapy
    • Erectile Dysfunction (ED) Treatment
    • Hormone Replacement Therapy (HRT)
    • +1 more
    Unverified listingView

The peptide world is changing. Stay informed.

You don’t have to be ready to see a provider to keep learning. Subscribers receive:

  • New educational resources
  • Research updates in plain English
  • Important industry and regulatory developments
  • Guidance for navigating your peptide therapy journey
I am a…

We’ll only use your email to send PeptideMatch.io updates. Unsubscribe anytime. See our Privacy Policy.